MedPath

江苏远恒药业有限公司

Ownership
-
Established
2002-02-09
Employees
-
Market Cap
-
Website
http://www.farever.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

56

NMPA:56

Drug Approvals

Diquafosol Sodium Eye Drops

Product Name
地夸磷索钠滴眼液
Approval Number
国药准字H20249234
Approval Date
Oct 29, 2024
NMPA

Timolol Maleate Eye Drops

Product Name
马来酸噻吗洛尔滴眼液
Approval Number
国药准字H20249112
Approval Date
Oct 22, 2024
NMPA

Timolol Maleate Eye Drops

Product Name
马来酸噻吗洛尔滴眼液
Approval Number
国药准字H20249113
Approval Date
Oct 22, 2024
NMPA

Flutrimazole Cream

Product Name
氟曲马唑乳膏
Approval Number
国药准字H20180014
Approval Date
Aug 9, 2023
NMPA

Compound Sodium Chloride Drops

Product Name
复方氯化钠滴眼液
Approval Number
国药准字H20083660
Approval Date
Apr 17, 2023
NMPA

消炎癣湿药膏

Approval Number
国药准字Z20217019
Approval Date
May 31, 2021
NMPA

Clotrimazole Suppositories

Product Name
克霉唑栓
Approval Number
国药准字H20063855
Approval Date
Mar 1, 2021
NMPA

Lincomycin Hydrochioride and Vitamin B6 Cream

Product Name
林可霉素维B6乳膏
Approval Number
国药准字H20066069
Approval Date
Feb 19, 2021
NMPA

Lomefloxacin Hydrochlocride Eye Drops

Product Name
盐酸洛美沙星滴眼液
Approval Number
国药准字H20066642
Approval Date
Feb 19, 2021
NMPA

Metronidazole,Clotrimazole and Chlorhexidine Acetate Suppositories

Product Name
双唑泰栓
Approval Number
国药准字H20065929
Approval Date
Feb 19, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.